Glycosulfatase activity of Helicobacter pylori toward gastric mucin
- PMID: 1372502
- DOI: 10.1016/0006-291x(92)90511-i
Glycosulfatase activity of Helicobacter pylori toward gastric mucin
Abstract
A glycosulfatase activity toward sulfated gastric mucus glycoprotein was identified in the extracellular material elaborated by H. pylori, a bacteria implicated in the etiology of gastric disease. Upon acetone precipitation, an active enzyme fraction at 64% acetone was obtained which on SDS-PAGE gave a major 30kDa protein band. The H. pylori glycosulfatase exhibited maximum activity (314.8 pmol/mg protein/h) at pH 5.7 in the presence of Triton X-100 and CaCl2, and was capable of removal of the sulfate ester groups situated at C-6 of N-acetylglucosamine, galactose and glucose. However, the enzyme was ineffective toward galactosylceramide and lactosylceramide sulfates which contain the sulfate ester group on C-3 of galactose. The results suggest that H. pylori is capable of overcoming the interference by sulfated mucus glycoprotein with its colonization of gastric mucosa.
Similar articles
-
Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.Am J Gastroenterol. 1992 Sep;87(9):1132-7. Am J Gastroenterol. 1992. PMID: 1381553
-
Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.Biochem Int. 1992 May;26(6):1091-9. Biochem Int. 1992. PMID: 1632804
-
Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.J Physiol Pharmacol. 1993 Mar;44(1):7-16. J Physiol Pharmacol. 1993. PMID: 8518427
-
Gastroprotective agents in mucosal defense against Helicobacter pylori.Gen Pharmacol. 1994 Sep;25(5):833-41. doi: 10.1016/0306-3623(94)90084-1. Gen Pharmacol. 1994. PMID: 7835626 Review.
-
Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.Arzneimittelforschung. 1997 Apr;47(4A):475-82. Arzneimittelforschung. 1997. PMID: 9205747 Review.
Cited by
-
Isolation, Characterization and Biosafety Evaluation of Lactobacillus Fermentum OK with Potential Oral Probiotic Properties.Probiotics Antimicrob Proteins. 2021 Oct;13(5):1363-1386. doi: 10.1007/s12602-021-09761-z. Epub 2021 Mar 13. Probiotics Antimicrob Proteins. 2021. PMID: 33715113
-
Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization.Eur J Pharm Biopharm. 2015 Oct;96:454-63. doi: 10.1016/j.ejpb.2015.01.010. Epub 2015 Jan 20. Eur J Pharm Biopharm. 2015. PMID: 25615880 Free PMC article. Review.
-
Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D.Microb Cell Fact. 2021 Mar 23;20(1):75. doi: 10.1186/s12934-021-01563-w. Microb Cell Fact. 2021. PMID: 33757506 Free PMC article.
-
Mucin glycan foraging in the human gut microbiome.Front Genet. 2015 Mar 19;6:81. doi: 10.3389/fgene.2015.00081. eCollection 2015. Front Genet. 2015. PMID: 25852737 Free PMC article. Review.
-
Helicobacter pylori infection does not reduce the viscosity of human gastric mucus gel.Gut. 1995 Mar;36(3):327-9. doi: 10.1136/gut.36.3.327. Gut. 1995. PMID: 7698685 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous